Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.42 - $0.65 $22,866 - $35,389
-54,445 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.54 - $2.74 $2,126 - $10,790
-3,938 Reduced 6.75%
54,445 $33,000
Q3 2021

Nov 15, 2021

SELL
$2.52 - $2.99 $229,665 - $272,499
-91,137 Reduced 60.95%
58,383 $161,000
Q2 2021

Aug 16, 2021

SELL
$2.6 - $3.65 $42,525 - $59,699
-16,356 Reduced 9.86%
149,520 $426,000
Q4 2020

Feb 16, 2021

BUY
$2.6 - $3.32 $28,267 - $36,095
10,872 Added 7.01%
165,876 $438,000
Q3 2020

Nov 17, 2020

BUY
$2.46 - $4.27 $2,462 - $4,274
1,001 Added 0.65%
155,004 $484,000
Q1 2020

May 13, 2020

BUY
$0.75 - $2.55 $36,809 - $125,151
49,079 Added 46.78%
154,003 $248,000
Q2 2019

Aug 14, 2019

BUY
$2.45 - $3.32 $257,063 - $348,347
104,924 New
104,924 $262,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $370M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.